Santilli F - Search Results

1

Thrombin as a common downstream target blocking both platelet and monocyte activation.

Santilli F, Davì G. Santilli F, et al. Thromb Haemost. 2009 Feb;101(2):220-1. Thromb Haemost. 2009. PMID: 19190800 No abstract available.

2

Low-density lipoprotein-lowering medication and platelet function.

Ferroni P, Basili S, Santilli F, Davì G. Ferroni P, et al. Among authors: santilli f. Pathophysiol Haemost Thromb. 2006;35(3-4):346-54. doi: 10.1159/000093226. Pathophysiol Haemost Thromb. 2006. PMID: 16877882 Review.

3

Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.

Pettinella C, Romano M, Stuppia L, Santilli F, Liani R, Davì G. Pettinella C, et al. Among authors: santilli f. Thromb Haemost. 2009 Apr;101(4):687-90. Thromb Haemost. 2009. PMID: 19350112 Clinical Trial.

4

Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation.

Lattanzio S, Santilli F, Vitale G, Caruso R, Davì V, Di Rosa S, Vazzana N, Ciabattoni G, Mansueto S, Davì G. Lattanzio S, et al. Among authors: santilli f. Thromb Res. 2010 Apr;125(4):362-4. doi: 10.1016/j.thromres.2009.06.010. Epub 2009 Jul 31. Thromb Res. 2010. PMID: 19647293 No abstract available.

5

Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism.

Dragani A, Falco A, Santilli F, Basili S, Rolandi G, Cerasa L, Lattanzio S, Ciabattoni G, Patrono C, Davì G. Dragani A, et al. Among authors: santilli f. Thromb Haemost. 2012 Sep;108(3):533-42. doi: 10.1160/TH11-12-0899. Epub 2012 Jul 10. Thromb Haemost. 2012. PMID: 22782530

6

Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis.

Santilli F, Vazzana N, Iodice P, Lattanzio S, Liani R, Bellomo RG, Lessiani G, Perego F, Saggini R, Davì G. Santilli F, et al. Thromb Haemost. 2013 Dec;110(6):1232-40. doi: 10.1160/TH13-04-0295. Epub 2013 Sep 12. Thromb Haemost. 2013. PMID: 24030807

7

Aspirin for primary prevention in diabetes mellitus: from the calculation of cardiovascular risk and risk/benefit profile to personalised treatment.

Santilli F, Pignatelli P, Violi F, Davì G. Santilli F, et al. Thromb Haemost. 2015 Nov;114(5):876-82. doi: 10.1160/TH15-03-0202. Epub 2015 Aug 6. Thromb Haemost. 2015. PMID: 26245672 Review.

8

Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment.

Di Sabatino A, Santilli F, Guerci M, Simeone P, Ardizzone S, Massari A, Giuffrida P, Tripaldi R, Malara A, Liani R, Gurini E, Aronico N, Balduini A, Corazza GR, Davì G. Di Sabatino A, et al. Among authors: santilli f. Thromb Haemost. 2016 Aug 30;116(3):486-95. doi: 10.1160/TH16-02-0167. Epub 2016 Jun 16. Thromb Haemost. 2016. PMID: 27305860

9

Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus.

Santilli F, Liani R, Di Fulvio P, Formoso G, Simeone P, Tripaldi R, Ueland T, Aukrust P, Davì G. Santilli F, et al. Thromb Haemost. 2016 Nov 30;116(6):1089-1099. doi: 10.1160/TH16-06-0471. Epub 2016 Oct 6. Thromb Haemost. 2016. PMID: 27709225

10

Unveiling the inflammatory face of antiplatelet drugs.

Davì G, Santilli F. Davì G, et al. Among authors: santilli f. J Thromb Haemost. 2006 Oct;4(10):2137-9. doi: 10.1111/j.1538-7836.2006.02123.x. Epub 2006 Jul 10. J Thromb Haemost. 2006. PMID: 16836652 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page